Abstract
Recent studies show that inflammation has an active role in the onset of neurodegenerative diseases. It is known that in response to extracellular insults microglia and/or astrocytes produce inflammatory agents. These contribute to the neuropathological events in the aging process and neuronal degeneration. Interleukin-6 (IL-6) has been involved in the pathogenesis of neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases. Here, we show that IL-6 treatment of rat hippocampal neurons increases the calcium influx via NMDA-receptor, an effect that is prevented by the specific NMDA receptor antagonist MK-801 (dizocilpine). We also show that this calcium influx is mediated by the JAKs/STATs pathway, since the inhibitor of JAKs/STATs pathway, JAK 3 inhibitor, blocks calcium influx even in the presence of IL-6. This increase in calcium signal was dependent on external sources, since this signal was not observed in the presence of EGTA. Additional studies indicate that the increase in cytosolic calcium induces tau protein hyperphos-phorylation, as revealed by using specific antibodies against Alzheimer phosphoepitopes. This anomalous tau hyperphosphorylation was dependent on both the JAKs/STATs pathway and NMDA receptor. These results suggest that IL-6 would induce a cascade of molecular events that produce a calcium influx through NMDA receptors, mediated by the JAKs/STATs pathway, which subsequently modifies the tau hyperphosphorylation patterns.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- Aß:
-
Amyloid beta peptide
- AD:
-
Alzheimer’s disease
- IL-6:
-
interleukin-6
- NMDA:
-
N-methyl-D-aspartate
References
Alvarez A, R Toro, A Caceres and RB Maccioni (1999) Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death.FEBSLett. 459, 421–426.
Alvarez A, JP Munoz and RB Maccioni (2001) A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons.Exp. Cell. Res. 264, 266–274.
Apelt J and R Schliebs (2001) Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.Brain Res. 894, 21–30.
Banker GA and WM Cowan (1977) Rat hippocampal neurons in dispersed cell culture.Brain Res. 126, 397–402.
Bauer J, S Strauss, B Volk and M Berger (1991) IL-6-mediated events in Alzheimer’s disease pathology.Immunol. Today 12, 422.
Blasko I, R Veerhuis, M Stampfer-Kountchev, M Saurwein-Teissl, P Eikelenboom and B Grubeck-Loebenstein (2000) Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1- 42 by human astrocytes.Neurobiol. Dis. 7, 682–689.
Blum-Degen D, T Muller, W Kuhn, M Gerlach, H Przuntek and P Riederer (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer’s andde novo Parkinson’s disease patients.Neurosci. Lett. 202, 17–20.
Campbell IL, CR Abraham, E Masliah, P Kemper, JD Inglis, MB Oldstone and L Mucke (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.Proc. Natl. Acad. Sci. USA 90, 10061–10065.
Chong Y (1997) Effect of a carboxy-terminal fragment of the Alzheimer’s amyloid precursor protein on expression of proin-flammatory cytokines in rat glial cells.Life Sci. 61, 2323–2333.
Del Bo R, N Angeretti, E Lucca, MG De Simoni and G Forloni (1995) Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures.Neurosci. Lett. 188, 70–74.
Ershler WB and ET Keller (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.Annu. Rev. Med. 51, 245–270.
Frei K, S Fredrikson, A Fontana and H Link (1991) Interleukin-6 is elevated in plasma in multiple sclerosis.J. Neuroimmunol. 31, 147–153.
Gadient RA and U Otten (1995) Interleukin-6 and interleukin-6 receptor mRNA expression in rat central nervous system.Ann. NY Acad. Sci. 762, 403–406.
Gadient RA and U Otten (1996) Postnatal expression of interleukin- 6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia.Brain Res. 724, 41–46.
Gadient RA and UH Otten (1997) Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials.Prog. Neurobiol. 52, 379–390.
Gadient RA, A Lachmund, K Unsicker and U Otten (1995) Expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat adrenal medulla.Neurosci. Lett. 194, 17–20.
Gijbels K, J Van Damme, P Proost, W Put, H Carton and A Billiau (1990) Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis.Eur. J. Immunol. 20, 233–235.
Gitter BD, LM Cox, RE Rydel and PC May (1995) Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells.Proc. Natl. Acad. Sci. USA 92, 10738–10741.
Grau GE, K Frei, PF Piguet, A Fontana, H Heremans, A Billiau, P Vassalli and P Lambert (1990) Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia.J. Exp. Med. 172, 1505–1508.
Harada T, T Morooka, S Ogawa and E Nishida (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1.Nat. Cell. Biol. 3, 453–459.
Holliday J, K Parsons, J Curry, SY Lee and DL Gruol (1995) Cerebellar granule neurons develop elevated calcium responses when treated with interleukin-6 in culture.Brain Res. 673, 141.
Jee SH, SY Chu, HC Chiu, YL Huang, WL Tsai, YH Liao and ML Kuo (2004) Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.J. Invest. Dermatol. 123, 1169–1175.
Jones SA, S Horiuchi, N Topley, N Yamamoto and GM Fuller (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease.FASEB J. 15, 43–58.
Kishimoto T, S Akira and T Taga (1992) Interleukin-6 and its receptor: a paradigm for cytokines.Science 258, 593–597.
LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease.Nat. Rev. Neurosci. 3, 862–872.
Lee MS, YT Kwon, M Li, J Peng, RM Friedlander and LH Tsai (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain.Nature 405, 360–364.
Li BS, MK Sun, L Zhang, S Takahashi, W Ma, L Vinade, AB Kulkarni, RO Brady and HC Pant (2001) Regulation of NMDA receptors by cyclin-dependent kinase-5.Proc. Natl. Acad. Sci. USA 98, 12742–12747.
Li Y, L Liu, SW Barger and WS Griffin (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway.J. Neurosci. 23, 1605–1611.
Mattson MP, B Cheng, D Davis, K Bryant, I Lieberburg and RE Rydel (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.J. Neurosci. 12, 376–389.
Mattson MP, KJ Tomaselli and RE Rydel (1993) Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.Brain Res. 621, 35–49.
Mehlhorn G, M Hollborn and R Schliebs (2000) Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.Int. J. Dev. Neurosci. 18, 423–431.
Merrill JE and IS Chen (1991) HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease.FASEB J. 5, 2391–2397.
Minami M, Y Kuraishi and M Satoh (1991) Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain.Biochem. Biophys. Res. Commun. 176, 593–598.
Patrick GN, L Zukerberg, M Nikolic, S de la Monte, P Dikkes and LH Tsai (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.Nature 402, 615–622.
Qiu Z, KL Parsons and DL Gruol (1995) Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons.J. Neurosci. 15, 6688–6699.
Qiu Z, DD Sweeney, JG Netzeband and DL Gruol (1998) Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons.J. Neurosci. 18, 10445–10456.
Quintanilla RA, OH Porras, J Castro and LF Barros (2000) Cytosolic [Ca(2+)] modulates basal GLUT1 activity and plays a permissive role in its activation by metabolic stress and insulin in rat epithelial cells.Cell Calcium 28, 97–106.
Quintanilla RA, DI Orellana, C Gonzalez-Billault and RB Maccioni (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway.Exp. Cell. Res. 295, 245–257.
Sengupta TK, EM Schmitt and LB Ivashkiv (1996) Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways.Proc. Natl. Acad. Sci. USA 93, 9499–9504.
Sengupta TK, ES Talbot, PA Scherle and LB Ivashkiv (1998) Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases.Proc. Natl. Acad. Sci. USA 95, 11107–11112.
Sriram K, SA Benkovic, MA Hebert, DB Miller and JP O’Callaghan (2004) Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosisin vivo?J. Biol. Chem. 279, 19936–19947.
Sudbeck EA, XP Liu, RK Narla, S Mahajan, S Ghosh, C Mao and FM Uckun (1999) Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.Clin. Cancer Res. 5, 1569–1582.
Toro VC, R Tehranian, M Zetterstrom, G Eriksson, U Langel, T Bartfai and K Iverfeld (2001) Increased gene expression of interleukin-1 alpha and interleukin-6 in rat primary glial cells induced by beta-amyloid fragment.J. Mol. Neurosci. 17, 341–350.
Tsai LH, I Delalle, VS Caviness Jr, T Chae and E Harlow (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.Nature 371, 419–423.
Viviani B, S Bartesaghi, F Gardoni, A Vezzani, MM Behrens, T Bartfai, M Binaglia, E Corsini, M Di Luca, CL Galliet al. (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases.J. Neurosci. 23, 8692–8700.
Wang J, S Liu, Y Fu, JH Wang and Y Lu (2003) Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors.Nat. Neurosci. 6, 1039–1047.
Wong EH, JA Kemp, T Priestley, AR Knight, GN Woodruff and LL Iversen (1986) The anticonvulsant MK-801 is a potentN-methyl-D-aspartate antagonist.Proc. Natl. Acad. Sci. USA 83, 7104–7108.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Orellana, D.I., Quintanilla, R.A., Gonzalez-Billault, C. et al. Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons. neurotox res 8, 295–304 (2005). https://doi.org/10.1007/BF03033983
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033983